logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 8652 352524; +7 8652 353229.

Fax
+7 8652 352524.

E-mail
medvestnik@stgmu.ru

Melaxen in correction of renal dysfunction in experimental lead poisoning

[Experimental medicine]
Vadim Brin; Astan Mitziev; Karmen Mitziev;

The aim was to investigate possible alteration of tubular apparatus sensitivity to vasopressin and its prevention by melaxen in chronic lead poisoning. Preventive application of melaxen reduces the severity of lead acetate toxic effects resulting in maintenance of renal sensitivity to antidiuretic hormone and consequence reduction of water excretion percent.

Download

References:
1.Brin V. B., Mittsiev A. K., Mittsiev K. G. Vestnik novyh medicinskih tehnologij. Bulletin of the new medical technologies. 2012;19(1):166-168.
2.Mittsiev A. K. Kubanskij nauchnyj medicinskij vestnik. – Kuban medical scientific Herald. 2008;(6):32-36.
3.Barbier O., Jacquillet G., Tauc M., Cougnon M., Poujeol P. Nephron Physiol. 2005;99(4):105-110.
4.Gagan F., Deepesh G., Archana T. Interdiscip Toxicol. 2012;5(2):47-58.
5.Sabath E., Robles-Osorio M. L. Nefrologia. 2012;32(3):279-286.
6.Sabolih I. Nephron Physiol. 2006;104(3):107-114.

Keywords: lead poisoning, vasopressin, melaxen, kidneys


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy